Thinking about cancer or dealing with cancer risk can be scary or overwhelming, but we believe that receiving information and resources is comforting, empowering, and lifesaving.
EMBRACA trial results: PARP inhibitors for metastatic breast cancer patients with BRCA mutations
FORCE summary of research findings from the EMBRACA study reported at San Antonio Breast Cancer Symposium.
BRCA mutation testing in determining breast cancer therapy
Smith, KL and Isaacs, C. Cancer J. 17(6):2011 Nov-Dec; Pages: 492-499.
This article reviews surgical and treatment options for management of affected BRCA mutation carriers with breast cancer.